4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The red blood cell proportion of arachidonic acid relates to shorter leukocyte telomeres in Mediterranean elders: A secondary analysis of a randomized controlled trial.

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Shortening of leukocyte telomere length (LTL) is a biomarker of aging. Epidemiologic studies of LTL in relation to dietary fatty acids have reported conflicting results. The red blood cell (RBC) fatty acid status is a valid objective biomarker of long-term dietary intake of C18:2n-6, C18:3n-3 and long-chain n-3 polyunsaturated fatty acids (C20:5n-3 and C22:6n-3). In healthy older individuals, we investigated whether LTL relates to the RBC proportions of the main dietary polyunsaturated fatty acids (PUFA), and to the RBC proportion of arachidonic acid (C20:4n-6), a fatty acid that can generate pro-inflammatory lipid mediators once released from cell membranes.

          Related collections

          Author and article information

          Journal
          Clin Nutr
          Clinical nutrition (Edinburgh, Scotland)
          Elsevier BV
          1532-1983
          0261-5614
          April 2019
          : 38
          : 2
          Affiliations
          [1 ] Lipid Clinic, Department of Endocrinology and Nutrition, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain.
          [2 ] Lipid Clinic, Department of Endocrinology and Nutrition, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain; Ciber Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
          [3 ] Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
          [4 ] Ciber Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Department of Preventive Medicine, University of Valencia, Valencia, Spain.
          [5 ] Department of Surgery, School of Medicine, University of Barcelona, Barcelona, Spain.
          [6 ] Department of Nutrition, School of Public Health, Loma Linda University, Loma Linda, CA, USA.
          [7 ] Lipid Clinic, Department of Endocrinology and Nutrition, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain; Ciber Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Electronic address: asala@clinic.ub.es.
          Article
          S0261-5614(18)30074-8
          10.1016/j.clnu.2018.02.011
          29478886
          743078aa-251f-47d5-be71-f48bf4518f51
          History

          Telomeres,Aging,Fatty acids,PUFA
          Telomeres, Aging, Fatty acids, PUFA

          Comments

          Comment on this article